These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39013686)

  • 1. Pholcodine and allergy to neuromuscular blocking agents. Comment on Br J Anaesth 2024; 132: 457-60.
    Baldo BA
    Br J Anaesth; 2024 Oct; 133(4):918-919. PubMed ID: 39013686
    [No Abstract]   [Full Text] [Related]  

  • 2. Pholcodine and allergy to neuromuscular blocking agents: where are we and how did we get here?
    Savic L; Hopkins PM
    Br J Anaesth; 2024 Mar; 132(3):457-460. PubMed ID: 38071149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of pholcodine-specific IgE in addition to morphine-specific IgE improves investigation of neuromuscular blocking agent anaphylaxis.
    Anderson J; Green S; Capon M; Krupowicz B; Li J; Fulton R; Fernando SL
    Br J Anaesth; 2020 Dec; 125(6):e450-e452. PubMed ID: 32600804
    [No Abstract]   [Full Text] [Related]  

  • 4. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
    Harboe T; Johansson SG; Florvaag E; Oman H
    Allergy; 2007 Dec; 62(12):1445-50. PubMed ID: 17983379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines.
    Rose MA; Anderson J; Green SL; Yun J; Fernando SL
    Acta Anaesthesiol Scand; 2018 May; 62(5):628-634. PubMed ID: 29368335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study.
    Sadleir PHM; Clarke RC; Goddard CE; Day C; Weightman W; Middleditch A; Platt PR
    Br J Anaesth; 2021 May; 126(5):940-948. PubMed ID: 33454050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents.
    de Pater GH; Florvaag E; Johansson SG; Irgens Å; Petersen MN; Guttormsen AB
    Allergy; 2017 May; 72(5):813-819. PubMed ID: 27859358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.
    Brusch AM; Clarke RC; Platt PR; Phillips EJ
    Br J Clin Pharmacol; 2014 Jul; 78(1):14-23. PubMed ID: 24251966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
    Florvaag E; Johansson SG; Irgens Å; de Pater GH
    Allergy; 2011 Jul; 66(7):955-60. PubMed ID: 21241314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'.
    Brusch AM; Clarke RC; Platt PR; Phillips E
    Br J Clin Pharmacol; 2014 Oct; 78(4):931-2. PubMed ID: 24611979
    [No Abstract]   [Full Text] [Related]  

  • 11. IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: Lessons from flow cytometry.
    Leysen J; De Witte L; Sabato V; Faber M; Hagendorens M; Bridts C; De Clerck L; Ebo D
    Cytometry B Clin Cytom; 2013 Mar; 84(2):65-70. PubMed ID: 23355309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-specific IgE testing in the assessment of neuromuscular blocking agent allergy. Comment on Br J Anaesth 2024; 132: 193-5.
    Ebo DG; Sabato V; Mertens C; Van Gasse AL
    Br J Anaesth; 2024 May; 132(5):976-977. PubMed ID: 38402108
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of a 1.0 mg ml(-1) aqueous pholcodine solution for allergy skin testing.
    Barbier P; Scala-Bertola J; Gambier N; Rivier A; Demoré B; Gillet P; Nicolas A; Petitpain N
    Br J Clin Pharmacol; 2014 Nov; 78(5):1172-4. PubMed ID: 24903072
    [No Abstract]   [Full Text] [Related]  

  • 14. [New insights into the role of pholcodine in the treatment of cough in 2013?].
    Blanchard E; Tunon de Lara M
    Therapie; 2013; 68(2):85-91. PubMed ID: 23773349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between pholcodine and perioperative anaphylaxis].
    Dumancić J; Marković AS
    Acta Med Croatica; 2012 May; 66(2):111-4. PubMed ID: 23437637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-specific IgE testing in the assessment of neuromuscular blocking agent allergy: a single centre experience.
    Chow KL; Patchett K; Reeves G; de Malmanche T; Gillies D; Boyle M
    Br J Anaesth; 2024 Jan; 132(1):193-195. PubMed ID: 37945415
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter to the authors concerning the accepted manuscript: exploring the link between pholcodine and neuromuscular anaphylaxis by Brush et al.
    Uyttebroek A; Leysen J; Bridts C; Ebo D
    Br J Clin Pharmacol; 2014 Oct; 78(4):929-30. PubMed ID: 24611952
    [No Abstract]   [Full Text] [Related]  

  • 18. Is pholcodine a dangerous cough suppressant?
    Ing Lorenzini K; Desmeules J; Piguet V
    Eur J Anaesthesiol; 2015 Nov; 32(11):749-50. PubMed ID: 26426574
    [No Abstract]   [Full Text] [Related]  

  • 19. Suspected pholcodine allergy: the conundrum of clinically irrelevant immunoglobulin E and basophil responsiveness to morphine and codeine.
    Ebo DG; Mertens C; Sabato V; Elst J
    Br J Anaesth; 2024 Apr; 132(4):808-810. PubMed ID: 38245453
    [No Abstract]   [Full Text] [Related]  

  • 20. Anesthesia in the patient with multiple drug allergies: are all allergies the same?
    Dewachter P; Mouton-Faivre C; Castells MC; Hepner DL
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):320-5. PubMed ID: 21494128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.